These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9710039)

  • 21. First-trimester exposure to alprazolam.
    St Clair SM; Schirmer RG
    Obstet Gynecol; 1992 Nov; 80(5):843-6. PubMed ID: 1407925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Revised estimates for probability of successful outcome of pregnancy after sumatriptan exposure.
    Fox AW
    Headache; 2004 Sep; 44(8):842-3. PubMed ID: 15330843
    [No Abstract]   [Full Text] [Related]  

  • 23. Sumatriptan and naratriptan tolerability and safety: an update of post-marketing experience.
    Welch KM
    Cephalalgia; 2001; 21 Suppl 1():25-8. PubMed ID: 11678818
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral sumatriptan-induced myocardial infarction.
    Hack JB
    J Toxicol Clin Toxicol; 2004; 42(3):309-11. PubMed ID: 15362600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective large-scale study of the tolerability of subcutaneous sumatriptan injection for acute treatment of migraine.
    O'Quinn S; Davis RL; Gutterman DL; Pait GD; Fox AW
    Cephalalgia; 1999 May; 19(4):223-31; discussion 200. PubMed ID: 10376167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and tolerability of sumatriptan after single-dose administration of a fixed-dose combination tablet of sumatriptan/naproxen sodium 85/500 mg followed two hours later by subcutaneous sumatriptan 4- or 6-mg injection: a randomized, open-label, three-period crossover study in healthy volunteers.
    Berges A; Walls C; Lener SE; McDonald SA
    Clin Ther; 2010 Jun; 32(6):1165-77. PubMed ID: 20637969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sumatriptan-induced growth hormone release in patients with major depression, mania, and normal controls.
    Yatham LN; Zis AP; Lam RW; Tam E; Shiah IS
    Neuropsychopharmacology; 1997 Oct; 17(4):258-63. PubMed ID: 9326750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients.
    Visser WH; Jaspers NM; de Vriend RH; Ferrari MD
    Cephalalgia; 1996 Dec; 16(8):554-9. PubMed ID: 8980858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring birth outcomes in the Sumatriptan Pregnancy Registry.
    Eldridge RR; Ephross SA
    Prim Care Update Ob Gyns; 1998 Jul; 5(4):190. PubMed ID: 10838359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of efavirenz in first-trimester of pregnancy: a systematic review and meta-analysis of outcomes from observational cohorts.
    Ford N; Mofenson L; Kranzer K; Medu L; Frigati L; Mills EJ; Calmy A
    AIDS; 2010 Jun; 24(10):1461-70. PubMed ID: 20479637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy outcome after first-trimester exposure to metformin: A prospective cohort study.
    Scherneck S; Schlinke N; Beck E; Grupe K; Weber-Schoendorfer C; Schaefer C
    Reprod Toxicol; 2018 Oct; 81():79-83. PubMed ID: 30017588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facial flushing: an uncommon presentation of serotonin toxicity.
    Deng M; Nedorost S
    Dermatitis; 2009; 20(5):296-7. PubMed ID: 19808008
    [No Abstract]   [Full Text] [Related]  

  • 33. Tolerability of sumatriptan: clinical trials and postmarketing experience.
    Allen C; Dayno J
    Cephalalgia; 2001 Oct; 21(8):855-6. PubMed ID: 11737014
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased rate of birth defects after first trimester use of angiotensin converting enzyme inhibitors - Treatment or hypertension related? An observational cohort study.
    Hoeltzenbein M; Tissen-Diabaté T; Fietz AK; Zinke S; Kayser A; Meister R; Weber-Schoendorfer C; Schaefer C
    Pregnancy Hypertens; 2018 Jul; 13():65-71. PubMed ID: 30177074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses.
    Moore KH; Hussey EK; Shaw S; Fuseau E; Duquesnoy C; Pakes GE
    Cephalalgia; 1997 Jun; 17(4):541-50. PubMed ID: 9209776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregnancy outcome after first trimester use of angiotensin AT1 receptor blockers: an observational cohort study.
    Hoeltzenbein M; Tissen-Diabaté T; Fietz AK; Zinke S; Kayser A; Meister R; Weber-Schoendorfer C; Schaefer C
    Clin Res Cardiol; 2018 Aug; 107(8):679-687. PubMed ID: 29574489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous chlorpromazine versus intramuscular sumatriptan for acute migraine.
    Kelly AM; Ardagh M; Curry C; D'Antonio J; Zebic S
    J Accid Emerg Med; 1997 Jul; 14(4):209-11. PubMed ID: 9248904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety, tolerability, and pharmacokinetics of sumatriptan suppositories following single and multiple doses in healthy volunteers.
    Kunka RL; Hussey EK; Shaw S; Warner P; Aubert B; Richard I; Fowler PA; Pakes GE
    Cephalalgia; 1997 Jun; 17(4):532-40. PubMed ID: 9209775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetal outcome after in utero exposure to cancer chemotherapy.
    Zemlickis D; Lishner M; Degendorfer P; Panzarella T; Sutcliffe SB; Koren G
    Arch Intern Med; 1992 Mar; 152(3):573-6. PubMed ID: 1546920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study.
    Bar-Oz B; Moretti ME; Bishai R; Mareels G; Van Tittelboom T; Verspeelt J; Koren G
    Am J Obstet Gynecol; 2000 Sep; 183(3):617-20. PubMed ID: 10992182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.